Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biodelivery Sci Intl (BDSI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 174,290
  • Shares Outstanding, K 55,330
  • Annual Sales, $ 15,550 K
  • Annual Income, $ -67,140 K
  • 36-Month Beta 1.00
  • Price/Sales 10.68
  • Price/Cash Flow 0.00
  • Price/Book 4.30

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.55 +27.45%
on 07/11/17
3.29 -1.22%
on 07/21/17
+0.50 (+18.18%)
since 06/21/17
3-Month
1.60 +103.13%
on 04/24/17
3.29 -1.22%
on 07/21/17
+1.65 (+103.13%)
since 04/21/17
52-Week
1.50 +116.67%
on 11/23/16
3.29 -1.22%
on 07/21/17
+0.85 (+35.42%)
since 07/21/16

Most Recent Stories

More News
Corporate News Blog - BioDelivery Sciences Collaborates with Canada's Purdue Pharma for Exclusive Distribution, Marketing, and Sale of BELBUCA(R)

LONDON, UK / ACCESSWIRE / July 14, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for BioDelivery Sciences International, Inc. (NASDAQ: BDSI) ("BioDelivery...

BDSI : 3.25 (+3.17%)
BioDelivery-Purdue Pharma Ink Marketing Deal for Pain Drug

BioDelivery Sciences International, Inc. (BDSI) announced an exclusive partnership agreement with Purdue Pharma, a Canadian pharmaceutical company, for commercializing its pain drug Belbuca in Canada....

ENZ : 11.35 (-1.05%)
ENDP : 12.38 (+0.49%)
BDSI : 3.25 (+3.17%)
EXEL : 27.23 (+0.89%)
BioDelivery Sciences Signs Exclusive Agreement With Purdue Pharma (Canada) For The Licensing And Distribution Rights Of BELBUCA® In Canada

Today, BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, and Purdue Pharma (Canada) announce that they...

BDSI : 3.25 (+3.17%)
Health Canada approves BioDelivery Sciences' BELBUCA

Pharmaceutical company BioDelivery Sciences International Inc (NASDAQ:BDSI) reported on Friday the receipt of Health Canada's Notice of Compliance (NOC) approving BELBUCA (buprenorphine hydrochloride buccal...

BDSI : 3.25 (+3.17%)
BioDelivery Sciences Announces Health Canada Approval of BELBUCA®

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Health Canada, the regulatory authority in Canada, has issued a Notice of Compliance (NOC) approving BELBUCA® (buprenorphine hydrochloride...

BDSI : 3.25 (+3.17%)
BioDelivery Inks New Contract with CVS/Caremark, Shares Up

BioDelivery Sciences International, Inc. (BDSI) announced an agreement with CVS/Caremark to extend access to its pain management product Belbuca and opioid dependence product Bunavail through 2020.

CVS : 77.03 (-0.17%)
ENDP : 12.38 (+0.49%)
BDSI : 3.25 (+3.17%)
REGN : 515.92 (-1.00%)
BioDelivery Sciences Announces Agreement with CVS/Caremark for BELBUCA® and BUNAVAIL® Through 2020

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has signed an agreement with CVS/Caremark extending access to both BELBUCA® (buprenorphine) buccal film (CIII) and BUNAVAIL®...

BDSI : 3.25 (+3.17%)
BioDelivery Sciences (BDSI) Up 16.7% Since Earnings Report: Can It Continue?

BioDelivery Sciences (BDSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BDSI : 3.25 (+3.17%)
Today's Research Reports on Stocks to Watch: BioDelivery Sciences International and Zosano Pharma

NEW YORK, NY / ACCESSWIRE / May 30, 2017 / While still not anywhere the highs of 2015's boom, the Biotech Industry has shown some signs of a comeback in 2017. After a dismal 2016, the iShares NASDAQ Biotechnology...

BDSI : 3.25 (+3.17%)
ZSAN : 1.32 (-1.49%)
XBI : 80.77 (+0.79%)
BioDelivery Sciences International (BDSI) Jumps: Stock Up 5%

BioDelivery Sciences International, Inc. (BDSI) shares rose over 5% in the last trading session.

AKTX : 4.63 (-1.28%)
BDSI : 3.25 (+3.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any...

See More

Support & Resistance

2nd Resistance Point 3.25
1st Resistance Point 3.20
Last Price 3.25
1st Support Level 3.05
2nd Support Level 2.95

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.